Details of the Drug Formulations

General Information of Drug (ID: DMCF6SX)

Drug Name
TAK-491 Drug Info
Synonyms TAK 491
Indication
Disease Entry ICD 11 Status REF
Hypertension BA00-BA04 Phase 3 [1]
Cross-matching ID
PubChem CID
135409642
ChEBI ID
CHEBI:68845
CAS Number
863031-21-4
TTD ID
D0A2RA
ACDINA ID
D00055

Full List of Drug Formulations Containing This Drug

Azilsartan medoxomil 40 mg tablet
Company Formulation ID FDA Description
Arbor Pharmaceuticals F02126 Fumaric acid; Magnesium stearate; Mannitol; Sodium hydroxide; Croscarmellose sodium; Hydroxypropyl cellulose (1200000 mw); Microcrystalline cellulose
Takeda Pharmaceuticals America F02127 Fumaric acid; Magnesium stearate; Mannitol; Sodium hydroxide; Croscarmellose sodium; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h)
------------------------------------------------------------------------------------
Azilsartan medoxomil 80 mg tablet
Company Formulation ID FDA Description
Arbor Pharmaceuticals F02128 Fumaric acid; Magnesium stearate; Mannitol; Sodium hydroxide; Croscarmellose sodium; Hydroxypropyl cellulose (1200000 mw); Microcrystalline cellulose
Takeda Pharmaceuticals America F02129 Fumaric acid; Magnesium stearate; Mannitol; Sodium hydroxide; Croscarmellose sodium; Cellulose, microcrystalline; Hydroxypropyl cellulose (type h)
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02480764) TAK-491 (Azilsartan Medoxomil) Compared to Valsartan in Chinese Participants With Hypertension.